Treatment of Herpes Zoster Blepharitis
For herpes zoster blepharitis, initiate systemic antiviral therapy with valacyclovir 1000 mg three times daily or famciclovir 500 mg three times daily for 7-10 days, ideally within 72 hours of rash onset, combined with topical corticosteroids and supportive eyelid hygiene measures. 1, 2
Immediate Antiviral Management
The cornerstone of treatment is early systemic antiviral therapy, which must be started within 72 hours of symptom onset to prevent vision-threatening complications 3. The most effective options based on high-quality evidence are:
- Valacyclovir 1000 mg three times daily for 7 days (preferred due to superior pharmacokinetics and convenient dosing) 1
- Famciclovir 500 mg three times daily for 7 days (equally effective alternative) 1
- Acyclovir 800 mg five times daily for 7 days (less convenient dosing)
Valacyclovir and famciclovir demonstrate 36-46% reduction in herpes zoster-associated pain at 21-30 days compared to acyclovir, with a number needed to treat of 3 1. These agents are particularly critical in herpes zoster ophthalmicus to prevent ocular complications including keratitis, uveitis, and vision loss 4, 5.
Topical Therapy
Topical corticosteroids should be used judiciously to control inflammation:
- Loteprednol etabonate 0.5%/tobramycin 0.3% suspension is preferred over dexamethasone due to lower risk of intraocular pressure elevation 6
- Topical antibiotics (bacitracin or erythromycin ointment) applied to eyelid margins to prevent secondary bacterial infection 6
Supportive Eyelid Care
Implement standard blepharitis management protocols 6:
- Warm compresses for several minutes, 1-2 times daily to soften crusts and secretions
- Gentle eyelid cleansing with diluted baby shampoo or hypochlorous acid 0.01% solution
- Eyelid massage to express meibomian glands if posterior involvement present
- Artificial tears for symptomatic relief
Pain Management
Appropriately dosed analgesics combined with neuroactive agents (amitriptyline) should be initiated early alongside antiviral therapy to prevent postherpetic neuralgia 3.
Critical Timing and Monitoring
Urgent ophthalmology consultation is mandatory for any suspected herpes zoster ophthalmicus, as approximately 50% develop ocular disease and up to 25% develop chronic or recurrent complications 4. The presence of Hutchinson's sign (vesicles on the nose tip) indicates nasociliary nerve involvement and high risk for ocular complications 5.
Long-term Suppressive Therapy
For patients with recurrent episodes, consider suppressive valacyclovir 1000 mg daily for 12 months, which reduces multiple episodes of keratitis or iritis (HR 0.70 at 12 months, 0.72 at 18 months) 2. This is particularly important for patients who develop stromal keratitis, endothelial keratitis, or iritis within the first year 2.
Prevention
Recombinant zoster vaccine (RZV) is highly effective at preventing herpes zoster ophthalmicus and should be recommended for all adults ≥50 years, including those with prior herpes zoster episodes 4, 7.
Common Pitfalls
- Delayed treatment beyond 72 hours significantly reduces antiviral efficacy 3
- Failure to recognize zoster sine herpete (ocular involvement without rash) - maintain high suspicion and consider PCR testing 5
- Inadequate pain control increases risk of postherpetic neuralgia 3
- Overly aggressive eyelid manipulation in patients with neurotrophic corneas can cause epithelial injury 6
- Missing delayed complications - multiple ocular complications can occur 6+ weeks after initial rash resolution, requiring vigilant follow-up 8